MedPath

Proactive Health Support

Not Applicable
Completed
Conditions
Patients at Risk of Hospital Admission
Registration Number
NCT03628469
Lead Sponsor
Frederiksberg University Hospital
Brief Summary

Proactive Health Support is a randomized controlled trial of telephone-based self-management support. The primary aim of the intervention is to reduce hospital admissions and improve quality of life in patients with a high risk of hospital admission.

Detailed Description

Participants are identified through an algorithm, that assigns each patient with a risk score of 0-100%. Patients with the highest risk in each of the five regions of Denmark are invited to participate.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5454
Inclusion Criteria
  • Persons with a hospital contact within the last year caused by ≥ 1 of the following diagnoses: heart diseases (DI110, DI130, DI132, DI50), connective tissue diseases (DD86, DM05, DM06, DM08, DM09, DM30, DM31, DM32, DM33, DM34, DM35, DM36), pulmonary diseases (DJ40, DJ41, DJ42, DJ43, DJ44, DJ45, DJ46, DJ47, DJ60, DJ61, , DJ62, DJ63, DJ64, DJ65, DJ66, DJ67, DJ684, DJ701, DJ703, DJ841, DJ842, DJ843, DJ848, DJ849, DJ920, DJ961, DJ982, DJ983) or diabetes (DE10, DE11, DE14) Or
  • Persons ≥ 18 years and ≥ three unplanned hospital admissions in the last six months Or
  • Persons ≥ 65 years with a preventable hospital admission (predefined diagnoses: dehydration, constipation, lower respiratory tract infections, urinary tract infections, gastroenteritis, fractures, nutrition deficiency anemia, social causes and pressure ulcers) or a readmission (within 30 days)
Exclusion Criteria
  • Selected psychiatric diagnoses: substance abuse disorder (DF1), schizophrenia (DF2) or dementia (DF00, DF01, DF02, DF03, DF051)
  • Metastatic cancer (DC77, DC78, DC79, DC80)
  • Assisted living Facility
  • Documented terminal illness or life expectancy < one year
  • Assessment of dementia
  • Major surgery planned within 6 months
  • Hearing impairment
  • Not speaking Danish
  • Cognitive impairment
  • Substance abuse, that impairs adherence
  • No telephone
  • Receiving similar trial intervention
  • Other (including intervention not suitable)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Hospital admissions6 months
Quality of life6 months

Questionnaire SF 36 - Mental Health Composite Score (Norm-based T-score of 45-55 is considered normal)

Secondary Outcome Measures
NameTimeMethod
Survival1 year
Patient education3, 6 and 12 months

Questionnaire Hei-Q - all 8 subscales (health-directed activities, positive and active engagement in life, emotional distress, self-monitoring and insight, constructive attitudes and approaches, skill and technique acquisition, social integration and support, health service navigation, range 1-4)

Incremental cost effectiveness ratio by comparison of costs with quality adjusted life years3, 6 and 12 months
Regional differences in resource use and costs3, 6 and 12 months
Outpatient consultations3, 6 and 12 months
Use of primary healthcare3, 6 and 12 months
Use of prescription medication3, 6 and 12 months
Resource use in primary care and rehabilitation3, 6 and 12 months
Quality of life3, 6 and 12 months

Questionnaire SF36: All eight subscales (physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, mental health and health transition, range 0-100. Furthermore, norm-based T-scores are reported, 45-55 is considered normal) and two composite scores (mental and physical health, norm-based T-score of 45-55 is considered normal)

Trial Locations

Locations (1)

Center for Clinical Research and Prevention

🇩🇰

Frederiksberg, Denmark

Center for Clinical Research and Prevention
🇩🇰Frederiksberg, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.